1. Home
  2. HALO vs ADC Comparison

HALO vs ADC Comparison

Compare HALO & ADC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • ADC
  • Stock Information
  • Founded
  • HALO 1998
  • ADC 1971
  • Country
  • HALO United States
  • ADC United States
  • Employees
  • HALO N/A
  • ADC N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • ADC Real Estate Investment Trusts
  • Sector
  • HALO Health Care
  • ADC Real Estate
  • Exchange
  • HALO Nasdaq
  • ADC Nasdaq
  • Market Cap
  • HALO 7.4B
  • ADC 8.5B
  • IPO Year
  • HALO N/A
  • ADC 1994
  • Fundamental
  • Price
  • HALO $52.81
  • ADC $74.75
  • Analyst Decision
  • HALO Buy
  • ADC Buy
  • Analyst Count
  • HALO 9
  • ADC 14
  • Target Price
  • HALO $63.56
  • ADC $80.65
  • AVG Volume (30 Days)
  • HALO 1.7M
  • ADC 1.0M
  • Earning Date
  • HALO 08-05-2025
  • ADC 07-22-2025
  • Dividend Yield
  • HALO N/A
  • ADC 4.05%
  • EPS Growth
  • HALO 55.40
  • ADC 4.57
  • EPS
  • HALO 3.76
  • ADC 1.77
  • Revenue
  • HALO $1,084,306,000.00
  • ADC $636,802,000.00
  • Revenue This Year
  • HALO $25.77
  • ADC $12.74
  • Revenue Next Year
  • HALO $18.01
  • ADC $10.64
  • P/E Ratio
  • HALO $14.04
  • ADC $42.33
  • Revenue Growth
  • HALO 25.64
  • ADC 13.65
  • 52 Week Low
  • HALO $42.01
  • ADC $60.42
  • 52 Week High
  • HALO $70.51
  • ADC $79.65
  • Technical
  • Relative Strength Index (RSI)
  • HALO 41.21
  • ADC 54.71
  • Support Level
  • HALO $53.54
  • ADC $73.17
  • Resistance Level
  • HALO $55.60
  • ADC $75.82
  • Average True Range (ATR)
  • HALO 1.24
  • ADC 1.06
  • MACD
  • HALO 0.09
  • ADC 0.12
  • Stochastic Oscillator
  • HALO 4.62
  • ADC 90.57

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About ADC Agree Realty Corporation

Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.

Share on Social Networks: